CONSOLIDATED
STATEMENT OF CASH FLOWS
|
Years
ended March 31, |
(In thousands) |
1998 |
|
1997 |
|
1996 |
|
|
Increase (decrease) in Cash and Cash
Equivalents |
|
|
CASH FLOWS FROM OPERATING
ACTIVITIES: |
Net income |
$ 126,587 |
|
$ 110,376 |
|
$ 101,454 |
Adjustments to reconcile net
income to net cash provided by
operating activities: |
|
Write-off
of in-process technology |
--- |
|
--- |
|
19,366 |
Depreciation
and amortization |
32,709 |
|
27,997 |
|
22,464 |
Undistributed
earnings of joint venture |
(3,747) |
|
(1,336) |
|
--- |
Changes in assets and
liabilities net of effects of NeoCAD
acquisition: |
|
Accounts
receivable |
11,336 |
|
7,280 |
|
(34,777) |
Inventories,
excluding receipts against advances for wafer
purchases |
7,469 |
|
(14,095) |
|
19,375 |
Deferred
income taxes and other |
15,644 |
|
14,134 |
|
(783) |
Accounts
payable, accrued liabilities and income taxes
payable |
8,861 |
|
(3,193) |
|
7,408 |
Deferred
income on shipments to distributors |
19,543 |
|
(1,213) |
|
15,755 |
|
|
Total
adjustments net of effects of NeoCAD acquisition |
91,815 |
|
29,574 |
|
48,808 |
|
|
Net
cash provided by operating activities |
218,402 |
|
139,950 |
|
150,262 |
|
|
|
CASH FLOWS FROM INVESTING
ACTIVITIES: |
Purchases of short-term available-for-sale
investments |
(337,500) |
|
(247,022) |
|
(292,013) |
Proceeds from sale or maturity of short-term
available-for-sale
investments |
352,149 |
|
303,604 |
|
92,333 |
Purchases of restricted held-to-maturity
investments |
(72,281) |
|
(72,227) |
|
(96,141) |
Proceeds from maturity of restricted
held-to-maturity investments |
72,267 |
|
72,189 |
|
72,555 |
Advances for wafer purchases |
(90,000) |
|
(60,000) |
|
--- |
Acquisition of NeoCAD, net of cash acquired |
--- |
|
--- |
|
(33,412) |
Property, plant and equipment |
(29,700) |
|
(26,803) |
|
(60,506) |
Investment in joint venture |
(67,422) |
|
--- |
|
(34,316) |
Deposit on building |
(28,351) |
|
--- |
|
--- |
Other |
--- |
|
--- |
|
(1,235) |
|
|
Net
cash used in investing activities |
(200,838) |
|
(30,259) |
|
(352,735) |
|
|
|
CASH FLOWS FROM FINANCING
ACTIVITIES: |
Net proceeds from issuance of long-term debt |
--- |
|
--- |
|
243,901 |
Acquisition of treasury stock |
(93,795) |
|
(32,028) |
|
--- |
Principal payments on capital lease obligations |
--- |
|
(977) |
|
(1,389) |
Proceeds from issuance of common stock |
27,189 |
|
28,324 |
|
14,151 |
|
|
Net
cash (used)/provided by financing activities |
(66,606) |
|
(4,681) |
|
256,663 |
|
|
Net (decrease)/increase in cash and cash
equivalents |
(49,042) |
|
105,010 |
|
54,190 |
Cash and cash equivalents at beginning of
period |
215,903 |
|
110,893 |
|
56,703 |
|
|
Cash and cash equivalents at end of period |
$ 166,861 |
|
$ 215,903 |
|
$ 110,893 |
|
|
|
SCHEDULE OF NON-CASH
TRANSACTIONS: |
Tax benefit from stock options |
$ 16,099 |
|
$ 16,730 |
|
$ 7,907 |
Issuance of treasury stock under employee stock
plans |
38,669 |
|
30,181 |
|
8,223 |
Receipts against advances for wafer purchases |
391 |
|
9,034 |
|
32,966 |
|
SUPPLEMENTAL DISCLOSURES OF CASH
FLOW INFORMATION: |
Interest paid |
13,008 |
|
13,309 |
|
201 |
Income taxes paid |
$ 39,472 |
|
$ 34,426 |
|
$ 74,688 |
|
See
accompanying notes. |
Return to Consolidated Financial
Statements
|